Hepatitis C virus dynamics and pathology: the role of CTL and antibody responses.

This paper investigates the role of CTL and antibody responses in hepatitis C virus (HCV) dynamics and pathology. Mathematical models suggest that a strong CTL response is required for resolution of HCV infection and that a weak CTL response can result in persistent infection. According to the model, establishment of persistent infection is accompanied mainly by an ongoing antibody response, while CTLs are not maintained at high levels. In the model, this outcome correlates with absence of pathology. Persistent infection in the face of an ongoing antibody response can result in evolution of antigenic escape. According to the model, evolution towards escape from antibodies can shift the balance of immune responses so that the weak CTL levels become increasingly more dominant relative to antibodies. This shift results in onset of liver pathology as the virus evolves towards increased levels of antigenic escape. Therefore, the relative balance of the immune response can be a decisive factor that determines whether patients are asymptomatic or whether pathology is observed. Virus evolution can shift this balance towards pathology over time. Theoretical results are discussed in the context of published data.

[1]  P. Klenerman,et al.  CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained , 2000, European journal of immunology.

[2]  A. Gabrielli,et al.  Quantitative analysis of hepatitis C virus activity in vivo in different groups of untreated patients , 1997, Archives of Virology.

[3]  P. Pontisso,et al.  Hepatitis C virus RNA profiles in chronically infected individuals: Do they relate to disease activity? , 1999, Hepatology.

[4]  D. W,et al.  Virus Dynamics : the Effect of Target Cell Limitation and Immune Responses on Virus Evolution , 1998 .

[5]  J. Borghans,et al.  Competition for antigenic sites during T cell proliferation: a mathematical interpretation of in vitro data. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Alan S. Perelson,et al.  Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy , 1998 .

[7]  R. Purcell,et al.  Quasispecies in viral persistence and pathogenesis of hepatitis C virus. , 1999, Trends in microbiology.

[8]  A. Barone,et al.  Hepatitis C viral load does not predict disease outcome: going beyond numbers. , 2002, Revista do Instituto de Medicina Tropical de Sao Paulo.

[9]  A. Zekry,et al.  Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection , 2000, Transplant infectious disease : an official journal of the Transplantation Society.

[10]  P. Klenerman,et al.  Viral escape and the failure of cellular immune responses. , 2000, Science.

[11]  A. Magrini,et al.  Serum HCV RNA titer does not predict the severity of liver damage in HCV carriers with normal aminotransferase levels. , 1999, Liver.

[12]  M A Nowak,et al.  Antigenic diversity thresholds and the development of AIDS. , 1991, Science.

[13]  T. Layden,et al.  Hepatitis C viral dynamics. , 1999, Clinics in liver disease.

[14]  Giorgio,et al.  Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[15]  P Parham,et al.  Analysis of a successful immune response against hepatitis C virus. , 1999, Immunity.

[16]  F. Chisari,et al.  Immunopathology of hepatitis C , 2004, Springer Seminars in Immunopathology.

[17]  P. Klenerman,et al.  Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers. , 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[18]  Dominik Wodarz,et al.  CD8 memory, immunodominance, and antigenic escape , 2000, European journal of immunology.

[19]  P. Farci Hepatitis C virus. The importance of viral heterogeneity. , 2001, Clinics in liver disease.

[20]  S. Einav,et al.  Immunopathogenesis of hepatitis C virus in the immunosuppressed host , 2002, Transplant infectious disease : an official journal of the Transplantation Society.

[21]  Dorothy M. Lang,et al.  Evolution of hepatitis C viral quasispecies after liver transplantation. , 2001, Gastroenterology.

[22]  F. Chisari,et al.  Differential CD4+ and CD8+ T‐cell responsiveness in hepatitis C virus infection , 2001, Hepatology.

[23]  F. Chisari,et al.  Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection , 2001, The Journal of experimental medicine.

[24]  S. Sauleda,et al.  Nucleotide and Amino Acid Complexity of Hepatitis C Virus Quasispecies in Serum and Liver , 2000, Journal of Virology.

[25]  H J Alter,et al.  The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. , 2000, Science.

[26]  C. Rice,et al.  Long-Term Follow-Up of Chimpanzees Inoculated with the First Infectious Clone for Hepatitis C Virus , 1999, Journal of Virology.

[27]  M. Nowak,et al.  Competitive coexistence in antiviral immunity. , 2000, Journal of theoretical biology.

[28]  B. Rocha,et al.  Population biology of lymphocytes: the flight for survival. , 2000, Annual review of immunology.

[29]  Dominik Wodarz,et al.  The importance of lytic and nonlytic immune responses in viral infections. , 2002, Trends in immunology.

[30]  J. Ball,et al.  Evolutionary trends of the first hypervariable region of the hepatitis C virus E2 protein in individuals with differing liver disease severity. , 2002, The Journal of general virology.

[31]  T. Liang,et al.  Emergence of a distinct pattern of viral mutations in chimpanzees infected with a homogeneous inoculum of hepatitis C virus. , 2001, Gastroenterology.

[32]  B. Walker,et al.  Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus , 2000, The Journal of experimental medicine.

[33]  J. Hoofnagle Management of hepatitis C: current and future perspectives. , 1999, Journal of hepatology.

[34]  C. Bréchot Hepatitis C virus , 1996, Digestive Diseases and Sciences.

[35]  T. Layden,et al.  Hepatitis C Kinetics: Mathematical Modeling of Viral Response to Therapy , 2000, Seminars in liver disease.